...Gianfranco Lapietra; Maria Luisa Moleti; Fiorina Giona; Arianna Turchetti; Mauro Celli; Alessandro Corsi; Anna Zambrano; Miriam D'Avanzo; Luca Celli; Anna Maria Testi Bone involvement in Hodgkin lymphoma (HL) is rare. The differential diagnosis between HL bone localization and other malignant...

...Jennifer Ding; Avnee J. Kumar; Emily Wilding; Seung Tae Lee; Jennie Y. Law Patients with HIV-associated lymphocyte-depleted Hodgkin lymphoma (HIV-HL) often present with advanced, extranodal disease and aggressive clinical features, limiting definitive therapeutic intervention. Here we report two...

...Oren Pasvolsky; Tamar Berger; Hanna Bernstine; Lucille Hayman; Pia Raanani; Liat Vidal Spontaneous regression of Hodgkin lymphoma (HL) is a rare event. We describe a 32-year-old woman with spontaneous regression of HL and review the literature. The patient presented with cervical lymphadenopathy...

...Nadav Sarid; Mor Zada; Shaul Lev-Ran; Eva Yashphe; Ido Givon; Merav Barzilai; Chava Perry; Irit Avivi; Ido Wolf Hodgkin lymphoma (HL) is one of the most curable malignancies. Despite its effectiveness, chemotherapy is often associated with adverse events (AEs) such as nausea, anorexia...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2016 Posttransplantation cyclophosphamide Hodgkin lymphoma Haploidentical stem cell transplantation Hematopoietic stem cell transplantation is an effective...

...Meirav Kedmi; Arie Apel; Tima Davidson; Itai Levi; Eldad J. Dann; Aaron Polliack; Isaac Ben-Bassat; Arnon Nagler; Abraham Avigdor The escalated BEACOPP (escBEACOPP) regimen improves the outcome of patients with advanced-stage Hodgkin lymphoma (HL) but is associated with cumbersome toxicity. We...

...Aurore Iltis; Veronique Eder; Helene Blasco; Philippe Colombat; Delphine Sénécal Background/Aims: An early evaluation with positron emission tomography (FDG-PET) has been demonstrated to be a valuable tool in the prediction of Hodgkin lymphoma's outcome. Herein we report a retrospective study...

...) and aggressive non-Hodgkin lymphoma (NHL). One hundred thirty-one examinations of 44 patients with early-stage (I-II) HL (n = 27) and aggressive NHL (n = 17) who had PET-CT performed as part of their initial staging and at follow-up were analyzed. Regardless of the extent of response to treatment...

...Daniel Shepshelovich; Ofer Shpilberg; Meir Lahav; Gilad Itchaki; Maxim Yakimov; Pia Raanani; Amos Cohen We report the development of hypothermia in a patient with Hodgkin lymphoma which resolved with chemotherapy administration. A review of the literature revealed 16 previous reports of hypothermia...

...Christine Herbst; Andreas Engert Meta-analyses have followed some of the most important advances in the treatment of early-stage Hodgkin lymphoma (HL). In this review, details on all meta-analyses of patients with early-stage HL are discussed. In 1990, the first meta-analysis addressing patients...

...Takayuki Saitoh; Takafumi Matsushima; Arito Yamane; Masataka Sakuraya; Hiroyuki Irisawa; Akihiko Yokohama; Hiroshi Handa; Norifumi Tsukamoto; Masamitsu Karasawa; Yoshihisa Nojima; Hirokazu Murakami Immunologic abnormalities have been described in patients with Hodgkin lymphoma, including autoimmune...